Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Interleukin 1 receptor antagonists].

A Lachaux1

  • 1Service d'hépatogastroentérologie infantile, hôpital Edouard-Herriot, Lyon, France.

Pediatrie
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Interleukin 1 (IL-1) is a key inflammatory mediator. The IL-1 receptor antagonist (IL-1ra) protein may regulate IL-1 activity and treat IL-1-mediated diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics and outcomes of patients with pediatric-onset non-mastocytosis mast cell activation disorders: A CEREMAST study.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same author

Epidemiology, clinical features, and mortality rate of Wilson disease in Moroccan children: A pediatric case series.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2022
Same author

[Current indications of ileo-colonoscopy in children in 2012].

Acta endoscopica·2020
Same author

Clinical Heterogeneity of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A French Multicenter Retrospective Study.

Clinical and translational gastroenterology·2018
Same author

TTC7A mutation must be considered in patients with repeated intestinal atresia associated with early inflammatory bowel disease: Two new case reports and a literature review.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2018
Same author

Single, short in-del, and copy number variations detection in monogenic dyslipidemia using a next-generation sequencing strategy.

Clinical genetics·2018
Same journal

[Colonic atresia: report of a case].

Pediatrie·1993
Same journal

[Psychological aspects of bone marrow donation in donor brothers and sisters in bone marrow transplantation].

Pediatrie·1993
Same journal

[Lethargy in the course of treatment with ranitidine in a newborn infant].

Pediatrie·1993
Same journal

[Delayed detection of hip dislocation: is the physician to blame?].

Pediatrie·1993
Same journal

[Renal tubular acidosis in children].

Pediatrie·1993
Same journal

[CD23: structures, functions and practical perspectives in allergy reactions].

Pediatrie·1993
See all related articles

Area of Science:

  • Immunology
  • Molecular Biology

Context:

  • Interleukin 1 (IL-1) is a cytokine with diverse biological activities, implicated in acute and chronic inflammatory diseases.
  • Understanding IL-1's role is crucial for developing targeted therapies.

Purpose:

  • To explore the significance of IL-1 receptor antagonist (IL-1ra) as a regulator of IL-1.
  • To investigate the therapeutic potential of IL-1ra in IL-1-mediated conditions.

Summary:

  • IL-1ra is a protein that inhibits IL-1 activity, potentially acting as a homeostatic mechanism.
  • Purification, characterization, and cDNA expression of IL-1ra have been reported.
  • Further research on IL-1ra is needed to elucidate its role in human physiology and pathology.

Impact:

Related Experiment Videos

  • IL-1ra may serve as a valuable tool for studying IL-1 functions.
  • IL-1ra shows promise as a therapeutic agent for inflammatory diseases mediated by IL-1.